Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-17 · accession 0000899243-21-036829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-21 | 2021-09-17 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +18.0K | 62.8K | +40% | +$12.1K |
| D | 2021-09-21 | 2021-09-17 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.00 | -18.0K | 247.4K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-17 | M | A | 18,012 | $0.67 | 62,773 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-09-17 | M | D | 18,012 | $0.00 | 247,402 | D | $0.67 · — to 2028-05-08 | 18,012 Common Stock | (F1) 25% of the shares subject to the stock option shall vest on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with the Company through such dates. |